Product NDC: | 0173-0776 |
Proprietary Name: | LAMICTAL |
Non Proprietary Name: | lamotrigine |
Active Ingredient(s): | 100 mg/1 & nbsp; lamotrigine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0776 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022251 |
Marketing Category: | NDA |
Start Marketing Date: | 20090605 |
Package NDC: | 0173-0776-02 |
Package Description: | 30 TABLET, ORALLY DISINTEGRATING in 1 DOSE PACK (0173-0776-02) |
NDC Code | 0173-0776-02 |
Proprietary Name | LAMICTAL |
Package Description | 30 TABLET, ORALLY DISINTEGRATING in 1 DOSE PACK (0173-0776-02) |
Product NDC | 0173-0776 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lamotrigine |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20090605 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | LAMOTRIGINE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |